Medical Practice Partnership Buy-In Guide: What Physicians Need to Know Before Signing (2026)

This guide explains how physician practice buy-ins actually work — how practices are valued, what a fair buy-in looks like across specialties, what structures are used to structure the payment, what ownership actually entitles you to, and the specific terms every physician must review before signing. Whether you are being offered partnership at a private practice, a multispecialty group, or a specialty-specific partnership in a high-value specialty, the framework here applies.

What Is a Medical Practice Buy-In and What Does It Actually Buy You?

A medical practice buy-in is the purchase of an ownership interest — equity — in an existing medical practice. When you buy in, you transition from employee to owner. That transition has clinical, operational, and financial dimensions that salary comparison alone cannot capture. Ownership is also less common than it used to be: in the AMA's 2024 Physician Practice Benchmark Survey, 35.4 percent of physicians had an ownership stake in their practice, down from 53.2 percent in 2012.

How Medical Practices Are Valued

The buy-in price is derived from the practice valuation. If you are purchasing 20 percent ownership in a practice valued at $1 million, your buy-in is $200,000. Understanding how the practice arrived at its stated value is essential before agreeing to pay.

Method 1: EBITDA Multiple (The Institutional Standard)

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization — a proxy for the cash a practice generates before accounting for how it is financed and how the owner takes money out.

No free, published survey reports what small medical practices sell for, and the multiples quoted in the industry vary widely by specialty, practice size, and buyer. The direction is consistent: physician-to-physician buy-ins are usually priced below what an outside buyer such as a private equity firm pays for a large group. The examples in this guide use 3x to 6x EBITDA for a physician-to-physician buy-in as an illustration, not a benchmark. Ask the practice to show how it chose its multiple.

The normalization step is critical and frequently disputed. This is why an independent accountant reviewing the numbers before you sign is not optional.

Method 2: Revenue Multiple (Collections Approach)

Simpler but less precise. The practice's annual net collections are multiplied by a percentage to arrive at value. Some smaller practices use a percentage of collections as a rough valuation shortcut. Revenue multiples are most useful for quick sanity checks and for practices where EBITDA is thin or volatile.

The significant weakness: Two practices with identical collections can have dramatically different profitability. A $5M cardiology practice with 25% margins is worth far more than a $5M practice with 8% margins. Revenue multiples ignore this reality.

Method 3: Asset-Based Valuation

The practice's tangible assets — equipment, receivables, furniture, real estate if owned — are valued and summed. Less common for ongoing practice buy-ins because it ignores the going-concern value of patient relationships, referral networks, staff, payer contracts, and established cash flow.

Goodwill: Personal vs. Practice — Understanding the Distinction

Goodwill is the value of a medical practice above and beyond its tangible assets — representing patient loyalty, reputation, established referral relationships, payer contracts, brand recognition, and systems. This is where buy-in valuations most commonly generate disputes.

• •Personal goodwill is goodwill attributable to a specific physician's reputation, skills, and relationships — goodwill that follows that physician rather than remaining with the practice.
• •Practice goodwill is goodwill attributable to the practice entity itself — location, staff quality, established patient panel, payer contracts, facility, and systems — goodwill that remains when any individual physician leaves.

In a physician-to-physician buy-in, you should be paying for practice goodwill, not personal goodwill. Asking you to pay for personal goodwill is asking you to pay for something that may evaporate if that physician leaves or reduces their role.

Specialty-Level Buy-In Expectations in 2026

Buy-in amounts vary dramatically by specialty based on practice profitability, ASC ownership value, ancillary service revenue, and local market dynamics. No published survey tracks buy-in prices by specialty, so treat the ranges below as rough, illustrative orders of magnitude for a 10% to 33% stake in 2026, not benchmarks. The number that matters is the one your practice's own financial statements support:

The ASC Ownership Buy-In: Where the Real Value Lives

For surgical specialties, the most financially significant component of a partnership buy-in is frequently not the practice itself but the associated ambulatory surgery center (ASC) ownership. As discussed in our Orthopedic Surgery Salary guide, a surgeon's share of an ASC's profit arrives as distributions on top of clinical salary, and for a high-volume surgeon those distributions can be substantial. How much depends on case volume, payer mix, the center's costs, and the size of the stake.

When evaluating a partnership offer that includes ASC ownership, always analyze the ASC's financial performance separately from the practice. Key metrics to review:

• 1.ASC EBITDA and operating margin: Ask for several years of results and look at the trend. A shrinking margin on steady case volume points to payer or cost problems.
• 2.Payer mix: An ASC with a predominantly commercial payer mix generates dramatically more per-case revenue than one dependent on Medicare.
• 3.Case volume trends: Is surgical volume growing, stable, or declining?
• 4.Ownership structure: What happens to your ownership if you retire, become disabled, or choose to leave the group?

ASC equity also comes with federal fraud-and-abuse rules. Returns on an ASC investment are protected by the Anti-Kickback Statute safe harbor for ambulatory surgical centers only when every condition is met. For a surgeon-owned center, the conditions include: the terms of your investment can't be tied to the volume of referrals you generate; at least one-third of each surgeon-investor's medical practice income must come from performing Medicare-covered ASC procedures; returns must be directly proportional to the capital each investor puts in; and neither the ASC nor its investors may lend you the money, or guarantee a loan, for your buy-in. That last condition matters if the center offers to finance your purchase, so ask the ASC's counsel how your investment fits the safe harbor.

Buy-In Structures: How the Payment Is Made

The mechanics of how you pay the buy-in amount matter significantly for your cash flow and tax situation.

Taxes depend on what you are buying as much as on how you pay. The split of the price among equipment, receivables, and goodwill, and whether you buy an existing partner's interest or contribute new capital to the entity, changes the result for you and for the selling partners. When goodwill is bought as part of a business's assets, the buyer amortizes it over 15 years under Section 197 of the Internal Revenue Code; buying shares or a partnership interest is treated differently. Have the CPA model the tax result before you agree to a structure.

Installment Purchase

A common structure. You pay the buy-in amount over a defined period, often several years, from your increased partner income. The critical question: Does your expected income increase exceed the annual installment payment by enough to justify the financial and administrative obligations of ownership?

Lump Sum Payment

Common in higher-value specialty practices and ASC equity transactions. Physicians frequently use practice loans to fund a lump sum buy-in. For example, a $300,000 buy-in loan at 8% over 7 years costs approximately $4,700 per month in loan service.

Sweat Equity / Earned Equity

The practice credits a portion of the economic value you generated as an associate against the buy-in price. Important to understand exactly how the earned equity is calculated and documented to avoid vague promises.

What You Must Evaluate Before Signing

How to Calculate Whether a Buy-In Is Worth It

A simple but effective framework uses the payback period — how many years it takes to recover the buy-in investment through incremental distributions:

Example: A gastroenterologist is offered partnership for a buy-in of $350,000. As an employee, they earn $520,000 per year. As a partner, they project distributions of $190,000 annually above their clinical salary. Annual income increase: $190,000. Payback period: $350,000 ÷ $190,000 = 1.8 years.

As a rule of thumb, a payback period under 3 years is favorable, 3 to 5 years is acceptable, and anything beyond 5 years warrants careful scrutiny.

The Private Equity Context: How PE Changes the Buy-In Calculus

Private equity has become a meaningful owner of physician practices, though hospitals still own far more. In the AMA's 2024 Physician Practice Benchmark Survey, 6.5 percent of physicians said their practice was private equity-owned, up from about 4.5 percent in 2020 and 2022, while 34.5 percent were in hospital-owned practices. For physicians evaluating a partnership buy-in at a practice that is either already PE-backed or likely to attract PE interest, the calculus differs:

• •If the practice is already PE-backed: You are buying a minority interest where a PE firm controls the majority. Governance rights are limited. The timeline to a "liquidity event" depends on when the firm plans to sell, often several years out. At that event, physician equity holders receive their proportional share of the purchase price — potentially a significant multiple of their buy-in investment.
• •If the practice is a likely PE acquisition target: Buying into a thriving private practice that subsequently gets acquired by PE can produce a significant windfall. As an illustration: paying $400,000 for 10% values the practice at $4 million. If the practice earns $1 million of EBITDA (a 4x buy-in multiple) and later sells at 8x that same EBITDA, the 10% stake is worth $800,000 before taxes and deal costs, double the buy-in. Larger payouts depend on the practice's earnings growing before the sale. This potential upside is one reason well-positioned specialty practices can command higher buy-in prices.

The Professional Team You Need for Any Buy-In

Do not attempt to evaluate or negotiate a medical practice buy-in without professional representation. Without independent review, you are making one of the largest financial decisions of your career without objective analysis. Fees vary with the market and the size of the deal, so get a written quote from each advisor before work starts.

• •Healthcare attorney: Reviews the partnership agreement, identifies unfavorable terms, negotiates modifications. Essential.
• •CPA with medical practice experience: Reviews the practice financial statements, validates the EBITDA normalization, assesses the valuation methodology. Essential.
• •Independent valuator: For buy-ins above $500,000, an independent practice valuation from an ASA or ABV-certified appraiser provides an objective fair market value opinion. Fair market value also matters legally: a price inflated or discounted to reward referrals can create problems under the federal Anti-Kickback Statute and physician self-referral (Stark) law.

For a comparison of financial advisors who specialize in physician practice transactions, see our financial advisors review page.

Red Flags That Warrant Serious Scrutiny

• ⚠️The buy-in price is calculated on collections, not EBITDA. A practice with 10% operating margins valued at 70% of collections is selling for 7x EBITDA — very rich for a physician-to-physician buy-in.
• ⚠️No audited or reviewed financial statements are available. Relying on internally generated spreadsheets creates opportunities for selective reporting.
• ⚠️The buy-in creates no meaningful governance rights. Buying a 10% stake where a majority partner controls all decisions is buying a minority position with little practical influence.
• ⚠️The non-compete is broader than the practice's actual service area.
• ⚠️The practice is acquiring new partners every 1 to 3 years. Frequent partner turnover signals governance disputes, distribution disagreements, or clinical culture problems.